The outsized cost of healthcare delivery in the U.S. may finally affect individual providers' treatment decisions. Some medical trade groups, such as the American Society of Clinical Oncology, the American Heart Association and the American College of Cardiology are compiling guidelines that blend treatment recommendations with cost considerations, the New York Times reported. The U.S. is under pressure to rein in costs, particularly since it spends $2.7 trillion on healthcare every year, and the country's outcomes are often unfavorable compared to nations that spend far less. Patients also now demand that the system provides greater price transparency. Read the full article from FierceHealthFinance